Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05587569 · ClinicalTrials.gov registry record · NA
Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
A NA study of Hallux Valgus and Metatarsus Adductus, sponsored by Treace Medical Concepts.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 9
- Study locations
NCT05587569 is a NA study of Hallux Valgus and Metatarsus Adductus that is actively recruiting participants, run by Treace Medical Concepts. The registered enrollment target is 80 participants, above the 64-participant average among 4 other Hallux Valgus trials with a reported enrollment target (25% higher). The trial reports 9 study locations across 8 states.
The verdict
NCT05587569, a NA study of Hallux Valgus and Metatarsus Adductus, is actively recruiting participants, sponsored by Treace Medical Concepts.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 9
- Study locations
Study Summary
Prospective, multicenter, unblinded study to evaluate outcomes of the Adductoplasty™ Procedure in combination with the Lapiplasty® Procedure for patients in need of metatarsus adductus and hallux valgus correction. Up to 80 subjects will be treated in this study at up to 13 clinical sites. Patients 14 years of age or older with symptomatic metatarsus adductus and hallux valgus will be eligible to participate based on the inclusion and exclusion criteria defined in the study protocol.
Conditions Studied
Interventions
- DEVICE Treatment of metatarsus adductus and hallux valgus with the Adductoplasty™ Procedure in combination with the Lapiplasty® Procedure
Study Locations (9)
Ohio
- Ohio Foot and Ankle Center - Canton
- Ohio Foot and Ankle Center - Stow
Colorado
- Foot and Ankle Center of the Rockies - Greeley
Iowa
- Foot and Ankle Center of Iowa - Ankeny
Maine
- Coastal Maine Foot and Ankle - Yarmouth
Missouri
- JCMG - Jefferson City Medical Group - Jefferson City
North Carolina
- Duke Orthopaedics Arringdon - Morrisville
Pennsylvania
- Greater Pittsburgh Foot and Ankle Center - Wexford
Texas
- Foot and Ankle Associates of North Texas - Keller - Keller
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-09-28 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05587569
The ClinicalTrials.gov registry entry for NCT05587569 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 64-participant average among 4 other Hallux Valgus trials with a reported enrollment target (25% higher). The listed sponsor is Treace Medical Concepts, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hallux Valgus appearing as the primary indexed condition, and to 1 intervention - of which Treatment of metatarsus adductus and hallux valgus with the Adductoplasty™ Procedure in combination with the Lapiplasty® Procedure is the first listed.
NCT05587569 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Ohio, Colorado, Iowa.
Frequently Asked Questions
What is clinical trial NCT05587569 about?
NCT05587569 is a clinical study titled "Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)". Prospective, multicenter, unblinded study to evaluate outcomes of the Adductoplasty™ Procedure in combination with the Lapiplasty® Procedure for patients in need of metatarsus adductus and hallux valgus correction. Up to 80 subjects will be treated in this study at up to 13 clinical sites. Patients...
What is the current status of trial NCT05587569?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-09-28. Estimated completion is 2030-12-31.
What conditions does trial NCT05587569 study?
This clinical trial studies the following conditions: Hallux Valgus, Metatarsus Adductus.
What interventions are being tested in trial NCT05587569?
The interventions under investigation include: Treatment of metatarsus adductus and hallux valgus with the Adductoplasty™ Procedure in combination with the Lapiplasty® Procedure (DEVICE).
Who is sponsoring clinical trial NCT05587569?
This trial is sponsored by Treace Medical Concepts, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05587569 being conducted?
This trial has 9 study locations across Colorado, Iowa, Maine, Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hallux Valgus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Weight-Bearing After the Lapiplasty Procedure
ACTIVE NOT RECRUITING · NA
-
Feasibility of an Analgesic Device Enabling Local Anesthetic Delivery and Neuromodulation After Shoulder/Foot Surgery
COMPLETED · NA
-
Patient Reported Function Following Combined First MTP and First TMT Arthrodesis.
COMPLETED · NA
-
Validation of Patient Reported Outcome Measures for Use in Hallux Valgus
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.